ICCR vs Bolus
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ICCR
This reference tool provides information on internal contamination with radionuclides and their medical countermeasures. It estimates reference concentrations in urine based on hypothetical patient scenarios and standard biokinetic models. The app is designed for professionals interested in radioactive material contamination and therapy.
- Radionuclide and medical countermeasure reference information
- Hypothetical patient scenario assessments
- Reference concentration estimation in urine
- Save, edit, and share assessments
- Information on internal contamination and therapy
Read full descriptionHide full description
The Internal Contamination Clinical Reference app is a reference tool to be used for educational and informational purposes only. The app provides information about internal contamination with a number of radionuclides and their medical countermeasure. The app estimates reference concentrations of radionuclides in urine using standard biokinetics models and assuming intakes equal to one Clinical Decision Guide (CDG) for each radionuclide based on hypothetical patient scenarios. The intended audience for the app is clinicians, health physicists, radiation safety officers, medical and public health laboratory scientists, or any other professional interested in internal contamination with radioactive materials and their medical therapy. Some basic understanding of concepts behind internal contamination and internal dosimetry are required to fully benefit from this application. The Internal Contamination Clinical Reference app features: * Reference information on a particular radionuclide or a medical countermeasure * Users can perform assessments based on hypothetical patient scenarios with each assessment projecting a reference concentration of radionuclides in urine based on user input * The assessment can be saved, edited and shared For more information, please visit http://www.cdc.gov/nceh/radiation/ or email rsbinfo@cdc.gov. This app was developed and produced by the Centers for Disease Control and Prevention http://www.cdc.gov/ and Oak Ridge Institute for Science and Education (ORISE) http://www.orau.gov/orise.htm through an interagency agreement with the U.S. Department of Energy (DOE). ORISE is managed by Oak Ridge Associated Universities under DOE contract number DE-AC05-06OR23100.
Bolus
This app streamlines anesthesia charting for medical professionals in office-based settings. It offers fast, one-handed data entry and generates clear, professional PDF records from pre-op to post-op, eliminating the need for paper charts.
- One-handed charting
- Fast data entry with presets
- Clean, structured anesthesia records
- Export to professional PDF
- Continuous workflow
- Local-only data storage
- Biometric authentication
Read full descriptionHide full description
Bolus is a mobile anesthesia record built for office-based sedation. Fast charting. Clear records. No paper. One continuous workflow from pre-op to post-op. Designed for: Anesthesiologists CRNAs Oral Surgeons Dentists providing IV sedation Mobile anesthesia providers Office based surgery practices Core features: One-handed charting during active cases Fast data entry with presets and favorites Clean, structured anesthesia records Export to professional PDF in seconds Workflow: Single continuous record from pre-op through recovery No switching between systems or paper charts Security: Local-only data storage AES-256 encryption Biometric authentication No patient data stored on external servers Bolus is a documentation tool only. It does not provide medical advice or clinical decision support. Built for daily clinical use, Bolus reduces paper-based friction and helps standardize charting across your workflow. It works offline, supports customizable snippets and consent forms, and is designed to make records easier to complete, review, and defend.
Screenshots
Verdict
The clearest difference is in-app purchases: ICCR at none against Bolus's 2. Bolus's advantage is update cadence (fortnightly vs every 33 months) and ratings volume (10 vs 2). On price, rating, ads and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Bolus sells 2 in-app purchases, starting at $58.00 per month. ICCR asks for nothing beyond the download.
On the App Store both sit at effectively the same score — 5.0 for ICCR against 5.0 for Bolus. That said, the two scores are not equally well evidenced: Bolus has 10 ratings behind it against 2, so its average is the more settled of the two.
ICCR ships an update every 33 months, Bolus fortnightly. The most recent releases landed on October 29, 2026 and October 9, 2026 respectively.
| Parameter | ICCR | Bolus |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (2 ratings) | 5.0 (10 ratings) |
| Positive reviews | — | 100.0% of reviews |
| Number of ratings | 2 | 10 — better |
| Update frequency | Every 33 months | Fortnightly — better |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free — better | Free with in-app purchases |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.6 | 15.1 — better |
| Further details — not scored | ||
| Size | 37 MB | 40 MB |
| Age rating | 12+ | 4+ |
| Developer | ORAU | Pressor Systems |
Customer experience
ICCR
Bolus
In-app purchases
ICCR
No in-app purchases
Bolus
- Professional Monthly$58.001 Month
- Professional Annual$589.001 Year









